Latest news
Desmoid Tumours Are Not Benign to the People Living With Them
FDA has accepted Immunome’s NDA for varegacestat in adults with progressing desmoid tumours. The label may say non-metastatic. The burden can still be brutal.
India’s Obesity Campaign Dispute Tests the Line Between Awareness and Promotion
England’s Tirzepatide Rollout Shows Approval Is Not Access
Medicare’s GLP-1 Bridge Turns Obesity Coverage Into a Public-Payer Experiment
WHO Makes Obesity Treatment a Global Access Test
Cyberbullying Becomes a Youth Mental Health Policy Target
Alzheimer’s Agitation Gets a New Drug, But Care Pathways Still Lag
Rare Epilepsy Moves Toward Treating the Cause
Huntington Gene Therapy Hits the Evidence Wall
Rare Disease Policy Moves Into the Individualised Therapy Era
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.